第18/2023號法律
| 第18/2023號法律 修改第17/2009號法律《禁止不法生產、販賣和吸食麻醉藥品及精神藥物》 2023年11月20日 |
| 《第18/2023號法律》經立法會於2023年11月7日通過本法律，行政長官賀一誠於2023年11月9日發佈本法律，並於2023年11月20日刊登於《澳門特別行政區公報》。 |
立法會根據《澳門特別行政區基本法》第七十一條（一）項，制定本法律。
第一條 修改第17/2009號法律的附表
[編輯]一、在經第4/2014號法律、第10/2016號法律、第10/2019號法律、第22/2020號法律及第10/2021號法律修改的第17/2009號法律第四條第二款所指的表一A、表二A、表二B及表二C中分別增加以下物質，該等物質載於作為本法律組成部分的附件一：
（一）表一A：
（1）奧列巴文；
（2）鄰氟芬太尼；
（3）異硝氮烯；
（4）溴啡；
（5）甲硝苯；
（二）表二A：
（1）3-甲氧基苯環利定；
（2）二苯基乙基哌啶；
（三）表二B：
（1）CUMYL-PEGACLON；
（2）MDMB-4en-PINACA；
（四）表二C：氟胺酮。
二、在第17/2009號法律第四條第四款所指的表四中，增加三種物質：氯氮唑侖、二氯西泮及氟溴唑侖；該等物質載於作為本法律組成部分的附件一。
三、在第17/2009號法律第四條第五款所指的表五中，增加三種物質：4-AP、1-boc-4-AP及去甲芬太尼；該等物質載於作為本法律組成部分的附件一。
第二條 修改表述
[編輯]第17/2009號法律的中文文本所表述的「阿片疊」改為「阿片劑」。
第三條 取代
[編輯]一、第17/2009號法律第十一條第二款所指的每日用量參考表，由作為本法律組成部分的附件二所載每日用量參考表取代。
二、第17/2009號法律第四條所指的表一至表六，分別由作為本法律組成部分的附件三所載表一至表六取代。
第四條 生效
[編輯]本法律自公佈翌日起生效。
二零二三年十一月七日通過。
立法會主席 高開賢
二零二三年十一月九日簽署。
命令公佈。
行政長官 賀一誠
附件一
[編輯]［第一條第一款（一）項所指者］ 表一A
[編輯]| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 133 | 奧列巴文 | Oripavina | 3-O-demethylthebaine |
| 134 | 鄰氟芬太尼 | Orthofluorofentanyl | N-(2-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide |
| 135 | 異硝氮烯 | Isotonitazene | N,N-diethyl-2-[2-(4-isopropoxybenzyl)-5-nitro--1H-benzo[d]imidazol-1-yl]ethan-1-amine |
| 136 | 溴啡 | Brorphine | 11-[1-(4-bromophenyl)ethyl]-piperidin-4-yl1,3-dihydro-2H-benzimidazol-2-one |
| 137 | 甲硝苯 | Metonitazene | N,N-diethyl-2-[2-(4-methoxybenzyl)-5-nitro-1H--benzo[d]imidazol-1-yl]ethan-1-amine |
［第一條第一款（二）項所指者］ 表二A
[編輯]| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 43 | 3-甲氧基苯環利定 | 3-Methoxyphencyclidine | 1-[1-(3-methoxyphenyl)cyclohexyl]piperidine |
| 44 | 二苯基乙基哌啶 | Diphenidine | 1-(1,2-diphenylethyl)piperidine |
［第一條第一款（三）項所指者］ 表二B
[編輯]| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 39 | CUMYL-PEGACLON | CUMYL-PEGACLON | 5-pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one |
| 40 | MDMB-4en-PINACA | MDMB-4en-PINACA | methyl 3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido]butanoate |
［第一條第一款（四）項所指者］ 表二C
[編輯]| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 14 | 氟胺酮 | 2-Fluorodeschloroketamine, 2-FDCK | 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one |
（第一條第二款所指者） 表四
[編輯]| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 65 | 氯氮唑侖 | Clonazolam | 6-(2-chlorophenyl)-1-methyl-8-nitro-4H- -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
| 66 | 二氯西泮 | Diclazepam | 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3--dihydro-2H-benzo[e][1,4]diazepin-2-one |
| 67 | 氟溴唑侖 | Flubromazolam | 8-bromo-6-(2-fluorophenyl)-1-methyl-4H--benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
（第一條第三款所指者） 表五
[編輯]| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 23 | 4-AP | 4-AP | 4-piperidinamine, N-phenyl- |
| 24 | 1-boc-4-AP | 1-boc-4-AP | 4-(phenylamino)-1-piperidinecarboxylic acid, 1,1-dimethylethyl ester |
| 25 | 去甲芬太尼 | Norfentanyl | propanamide, N-phenyl-N-4-piperidinyl- |
附件二 （第三條第一款所指者） 每日用量參考表
[編輯]| 序號 | 最經常吸食的表一至表四所列植物、物質或製劑 | 表 | 每日參考用量【附註】 |
|---|---|---|---|
| 1. | 海洛因 | I-A | 0.25克【註1及註2】 |
| 2. | 美沙酮 | I-A | 0.1克【註2】 |
| 3. | 嗎啡 | I-A | 0.2克 |
| 4. | 阿片（罌粟汁凝固物） | I-A | 1克【註3-（2）】 |
| 5. | 鹽酸可卡因 | I-B | 0.2克【註2及註4】 |
| 6. | 可卡因（苯甲酰芽子鹼甲酯） | I-B | 0.03克【註2及註4】 |
| 7. | 大麻（植物的葉，或其開花或結果的頂部） | I-C | 1克【註1】 |
| 8. | 大麻樹脂 | I-C | 0.5克【註3-（3）及（4）】 |
| 9. | 大麻油 | I-C | 0.25克【註3-（5）】 |
| 10. | 苯環利定 | II-A | 0.01克【註3-（1）】 |
| 11. | 麥角二乙胺 | II-A | 0.0002克【註1】 |
| 12. | 亞甲二氧基甲基苯丙胺 | II-A | 0.15克【註3-（1）及（6）】 |
| 13. | 苯丙胺 | II-B | 0.2克【註1】 |
| 14. | 甲基苯丙胺 | II-B | 0.2克【註1】 |
| 15. | Δ-9-四氫大麻酚 | II-B | 0.05克 |
| 16. | 氯胺酮 | II-C | 0.6克【註3-（1）】 |
註：
1. 所指的參考量是按照國際麻醉品管制局（INCB — International Narcotics Control Board）的資料而制定。
2. 所指的參考量是按照有關慣常使用量的流行病學的資料而制定。
3. 所指的參考量為：
（1）官方藥物文件內所指的每日用量；
（2）效力相等於可參考的濫用物質的用量；
（3）按大麻產品所含的四氫大麻酚的平均含量的變數所定的每日平均用量；
（4）平均濃度為百分之十的Δ-9-四氫大麻酚；
（5）平均濃度為百分之二十的Δ-9-四氫大麻酚；
（6）在醫學文獻內所指的含有介乎80毫克至160毫克純正物質的慣常平均用量（ca. 2 mg/kg）。然而，某些物質亦有可能混有雜質（如替苯丙胺、咖啡因）或摻合了海洛因。
4. 由於鹽酸可卡因及苯甲酰芽子鹼甲酯的化學成分的效價存在明顯不同，因此特別對兩者訂定了不同的用量。
附件三 （第三條第二款所指者）
[編輯]表一 A
[編輯]| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 乙酰-α-甲基芬太尼 | Acetil-alfa-metilfentanil | N-[1-(α-methylphenethyl)-4-piperidyl]acetanilide |
| 2 | 醋氫可待因 | Acetildiidrocodeína | 4,5-epoxy-3-methoxy-17-methylmorphina-6-ol acetate) |
| 3 | 醋美沙朵 | Acetilmetadol | 3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
| 4 | 醋托啡 | Acetorfina | 3-O-acetyltetrahydro-7α-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine |
| 5 | 阿醋美沙朵 | Alfacetilmetadol | α-3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
| 6 | α-美羅定 | Alfameprodina | α-3-ethyl-1-methyl-4-phenyl-4- propionoxypiperidine |
| 7 | α-美沙多 | Alfametadol | α-6-dimethylamino-4,4-diphenyl-3-heptanol |
| 8 | α-甲基芬太尼 | Alfa-metilfentanil | N-[1-( α-methylphenethyl)-4- piperidyl]propionanilide |
| 9 | α-甲基硫代芬太尼 | Alfa-metiltiofentanil | N-[1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidyl]propionanilide |
| 10 | α-羅定 | Alfaprodina | α-1,3-dimethyl-4-phenyl-4-propionoxypiperidine |
| 11 | 阿芬他尼 | Alfentanil | N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl]- N-phenylpropanamide |
| 12 | 烯丙羅定 | Alilprodina | 3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine |
| 13 | 氨苄哌替啶 | Anileridina | 1-p-aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 14 | 聯苯胺 | Benzetidina | 1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 15 | 苄嗎啡 | Benzilmorfina | 3-benzylmorphine |
| 16 | β-乙酰美沙多 | Betacetilmetadol | β-3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
| 17 | β-羥基芬太尼 | Beta-hidroxifentanil | N-[1-(β-hydroxyphenethyl)-4-piperidyl]propionanilide |
| 18 | β-羥基-3-甲基芬太尼 | Beta-hidroxi-3-metil fentanil | N-[1-(β-hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide |
| 19 | β-美羅定 | Betameprodina | β-3-ethyl-1-methyl-4-phenyl-4- propionoxypiperidine |
| 20 | β-美沙多 | Betametadol | β-6-dimethylamino-4,4-diphenyl-3-heptanol |
| 21 | β-普魯汀 | Betaprodina | β-1,3-dimethyl-4-phenyl-4- propionoxypiperidine |
| 22 | 可待因 | Bezitramida | 1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benzimidazolinyl)piperidine |
| 23 | 嗎苯丁酯 | Butirato de dioxafetilo | ethyl-4-morpholino-2,2-diphenylbutyrate |
| 24 | 凱托米酮 | Cetobemidona | 4-m-hydroxyphenyl-1-methyl-4-propionylpiperidine |
| 25 | 氯尼他秦 | Clonitazeno | 2-(p-chlorobenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole |
| 26 | 可待因 | Codeína | 3-methylmorphine |
| 27 | 可待因-N-氧化物 | Codeína-N-óxido | 3-methoxy-4,5-epoxy-6-hydroxy-17-methyl-7-morphinan-17-oxy-ol |
| 28 | 可多克辛 | Codoxina | dihydrocodeinone-6-carboxymethyloxime |
| 29 | 罌粟草濃縮物 –罌粟草生物鹼經濃縮所得的質料。 |
Concentrado da cápsula de Papaver Somniferum L.– O produto obtido da cápsula da Papaver som niferum L. e submetido a processo para concentração dos seus alcalóides. |
|
| 30 | 地索嗎啡 | Desomorfina | dihydrodeoxymorphine |
| 31 | 右旋嗎拉胺 | Dextromoramida | (+)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine |
| 32 | 右旋丙氧吩 | Dextropropoxifeno | α-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate |
| 33 | 地恩丙胺 | Diampromida | N-[2-(methylphenethylamino)propyl]propionanilide |
| 34 | 二乙噻丁 | Dietiltiambuteno | 3-diethylamino-1,1-di(2'-thienyl)-1-butene |
| 35 | 地芬諾酯 | Difenoxilato | 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 36 | 氰苯哌酸 | Difenoxina | 1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotic acid |
| 37 | 雙氫可待因 | Diidrocodeína | (5α,6α)-4,5-Epoxy-3-methoxy-17-methylmorphinan-6-ol |
| 38 | 雙氫埃托啡 | Diidroetorfina | 7,8-dihydro-7α-[1-(R)-hydroxy-1-methylbutyl]-6,14-endo-ethanotetrahydrooripavine |
| 39 | 雙氫嗎啡 | Di-hidromorfina | (5α,6α)-4,5-Epoxy-17-methylmorphinan-3,6-diol |
| 40 | 地美庚醇 | Dimefeptanol | 6-dimethylamino-4,4-diphenyl-3-heptanol |
| 41 | 地美沙朵 | Dimenoxadol | 2-dimethylaminoethyl-1-ethoxy-1,1-diphenylacetate |
| 42 | 二甲噻丁 | Dimetiltiambuteno | 3-dimethylamino-1,1-di(2'-thienyl)-1-butene |
| 43 | 地匹哌酮 | Dipipanona | 4,4-diphenyl-6-piperidine-3-heptanone |
| 44 | 羥蒂巴酚 | Drotebanol | 3,4-dimethoxy-17-methylmorphinan-6 β,14-diol |
| 45 | 乙基甲嗯丁胺 | Etilmetiltiambuteno | 3-ethylmethylamino-1,1-di(2'-thienyl)-1-butene |
| 46 | 乙基嗎啡 | Etilmorfina | 3-ethylmorphine |
| 47 | 依託尼秦 | Etonitazeno | 1-diethylaminoethyl-2-p-ethoxybenzyl-5-nitrobenzimidazole |
| 48 | 羥戊甲嗎啡 | Etorfina | tetrahydro-7α-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine |
| 49 | 愛托失立汀 | Etoxeridina | 1-[2-(2-hydroxyethoxy)ethyl]-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 50 | 吩那多松 | Fenadoxona | 6-morpholino-4,4-diphenyl-3-heptanone |
| 51 | 非那丙胺 | Fenanpromida | N-(1-methyl-2-piperidinoethyl)propionanilide |
| 52 | 非那佐辛 | Fenazocina | 2'-hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan |
| 53 | 吩諾嗎凡口 | Fenomorfano | 3-hydroxy-N-phenethylmorphinan |
| 54 | 吩諾配立汀 | Fenopiridina | 1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 55 | 芬太尼 | Fentanil | 1-phenethyl-4-N-propionylanilinopiperidine |
| 56 | 嗎啉乙基嗎啡 | Folcodina | morpholinylethylmorphine |
| 57 | 呋替啶 | Furetidina | 1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 58 | 海洛因 | Heroína | diacetylmorphine |
| 59 | 二氫可待因酮 | Hidrocodona | dihydrocodeinone |
| 60 | 羥二氫嗎啡 | Hidromorfinol | 14-hydroxydihydromorphine |
| 61 | 二氫嗎啡酮 | Hidromorfona | dihydromorphinone |
| 62 | 羥基配西汀 | Hidroxipetidina | 4-m-hydroxyphenyl-1-methylpiperidine-4-carboxylic acid ethyl ester |
| 63 | 異美沙酮 | Isometadona | 6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone |
| 64 | 左旋吩納西嗎凡 | Levofenacilmorfano | (-)-3-hydroxy-N-phenacylmorphinan |
| 65 | 左旋美沙芬* | Levometorfano | (-)-3-methoxy-N-methylmorphinan |
| 66 | 左旋甲嗎拉密特 | Levomoramide | (-)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine |
| 67 | 左旋嗎喃* | Levorfanol | (-)-3-hydroxy-N-methylmorphinan |
| 68 | 美沙酮 | Metadona | 6-dimethylamino-4,4-diphenyl-3-heptanone |
| 69 | 美沙酮中間體 | Metadona,intermedi ário de | 4-cyano-2-dimethylamino-4,4-diphenylbutane |
| 70 | 美他佐辛 | Metazocina | 2'-hydroxy-2,5,9-trimethyl-6,7-benzomorphan |
| 71 | 甲基去氧嗎啡 | Meildesorfina | 6-methyl-∆6-deoxymorphine |
| 72 | 甲基雙氫嗎啡 | Metildiidromorfina | 6-methyldihydromorphine |
| 73 | 3-甲基芬太尼 | 3-metilfentanil | N-(3-methyl-1-phenethyl-4-piperidyl)propionanilide |
| 74 | 3-甲基硫代芬太尼 | 3-metiltiofentanil | N-[3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide |
| 75 | 美托邦 | Metopão | 5-methyldihydromorphinone |
| 76 | 肉豆蔻苯基嗎啡 | Mirofina | myristylbenzylmorphine |
| 77 | 嗎酰胺中間體 | Moramida, intermediário de | 2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid |
| 78 | 嗎乙哌 | Morferidina | 1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 79 | 嗎啡 | Morfina | (5α,6α)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol |
| 80 | 嗎啡, 含五價氮之嗎啡之溴甲烷及其他衍生物 | Morfina, bromometilato e outros derivados da morfina com nitrogénio pentavalente | |
| 81 | 嗎啡-N-氧化物 | Morfina-N-óxido | 3,6-dihydroxy-4,5-epoxy-17-methyl-morphinan-N-oxide |
| 82 | 仲氟代芬太尼 | MPPP | 1-methyl-4-phenyl-4-piperidinol propionate (ester) |
| 83 | 6-煙鹼可待因 | Nicocodina | 6-nicotinylcodeine |
| 84 | 3,6-二煙酰嗎啡 | Nicomorfina | 3,6-dinicotinylmorphine |
| 85 | 煙鹼酰二可待因 | Nicodicodina | 6-nicotinyldihydrocodeine |
| 86 | 去甲乙酰美沙多 | Noracimetadol | (±)-α-3-acetoxy-6-methylamino-4,4-diphenylheptane |
| 87 | 去甲可待因 | Norcodeína | N-demethylcodeine |
| 88 | 左旋3-羥嗎啡喃 | Norlevorfanol | (-)-3-hydroxymorphinan |
| 89 | 去甲美沙酮 | Normetadona | 6-dimethylamino-4,4-diphenyl-3-hexanone |
| 90 | 去甲嗎啡 | Normorfina | demethylmorphine |
| 91 | 二苯哌己酮 | Norpipanona | 4,4-diphenyl-6-piperidino-3-hexanone |
| 92 | 阿片 -從罌粟殼取得之自行凝結的 ,且僅經必需之包裝及運輸程序處理而不論其嗎啡含量之乳液。 |
Ópio- O suco coagulado espontaneamente obtido da cápsula da Papaver Som niferum L. e que não tenha sofrido mais do que as manipulações necessárias para o seu empacotamento e transporte, qualquer que seja o seu teor em morfina. |
|
| 93 | 阿片 多種生物鹼之氯化物及溴化物之混合物。 |
Ópio Mistura de alcalóides sob a forma de cloridratos e brometos. |
|
| 94 | 羥二氫可待因酮 | Oxicodona | 14-hydroxydihydrocodeinone |
| 95 | 羥二氫嗎啡酮 | Oximorfona | 14-hydroxydihydromorphinone |
| 96 | 仲氟代芬太尼 | Para-fluorofentanil | 4'-fluoro-N-(1-phenethyl-4-piperidyl)propionanilide |
| 97 | 1-苯乙基-4-苯基-4-哌啶丙酸鹽 | PEPAP | 1-phenethyl-4-phenyl-4-piperidinol acetate (ester) |
| 98 | 陪替丁 | Petidina | 1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 99 | 陪替丁中間體A | Petidina, intermediário A da | 4-cyano-1-methyl-4-phenylpiperidine |
| 100 | 陪替丁中間體B | Petidina, intermediário B da | 4-phenylpiperidine-4-carboxylic acid ethyl ester |
| 101 | 陪替丁中間體 | Petidina, intermediário C da | 1-methyl-4-phenylpiperidine-4-carboxylic acid |
| 102 | 匹密諾汀 | Piminodina | 4-phenyl-1-(3-phenylaminopropyl)piperidine-4-carboxylic acid ethyl ester |
| 103 | 哌腈米特 | Piritramida | 1-(3-cyano-3,3-diphenylpropyl)-4-(1-piperidino)piperidine-4-carboxylic acid amide |
| 104 | 普魯亥他淨 | Pro-heptazina | 1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane |
| 105 | 普魯散立汀 | Properidina | 1-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester |
| 106 | 丙吡胺 | Propiramo | N-(1-methyl-2-piperidinoethyl)-N-2-pyridylpropionamide |
| 107 | 外消旋甲嗎凡 | Racemétorfano | (±)-3-methoxy-N-methylmorphinan |
| 108 | 外消旋嗎拉密特 | Racemoramida | (±)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]morpholine |
| 109 | 外消旋嗎凡 | Racemorfano | (±)-3-hydroxy-N-methylmorphinan |
| 110 | 雷米芬太尼 | Remifentanilo | 1-(2-methoxycarbonylethyl)-4-(phenylpropionylamino)piperidine-4-carboxylic acid methyl ester |
| 111 | 舒吩太尼 | Sufentanil | N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide |
| 112 | 醋氫可酮 | Tabecão | acetyldihydrocodeinone |
| 113 | 蒂巴因 | Tebaína | (5α)-6,7,8,14-Tetradehydro-4,5-epoxy-3,6-dimethoxy-17-methylmorphinan |
| 114 | 替利定 | Tilidina | (±)-ethyl-trans-2-(dimethylamino)-1-phenyl-3-cyclohexene-1-carboxylate |
| 115 | 硫代芬太尼 | Tiofentanil | N-[1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide |
| 116 | 三甲利定 | Trimeperidina | 1,2,5-trimethyl-4-phenyl-4-propionoxypiperidine |
| 117 | 3,4-二氯-N-{[1-（二甲基氨基）環己基]甲基}苯甲酰胺 | AH-7921 | 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide |
| 118 | 乙酰芬太尼 | Acetylfentanyl | N-[1-(2-phenylethyl)-4-piperidyl]-N-phenylacetamide |
| 119 | 1-環己基-4（1,2-二苯基乙基）哌嗪 | MT-45 | 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine |
| 120 | U-47700 | U-47700 | 3,4-dichloro-N-(2-dimethylamino-cyclohexyl)-N-methyl-benzamide |
| 121 | 丁酰芬太尼 | Butyrfentanyl | N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]butanamide |
| 122 | 卡芬太尼 | Carfentanil | methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate |
| 123 | 奧芬太尼 | Ocfentanil | N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide |
| 124 | 呋喃芬太尼 | Furanylfentanyl | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl] furan-2-carboxamide |
| 125 | 丙烯酰芬太尼 | Acryloylfentanyl (Acrylfentanyl) | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]prop-2-enamide |
| 126 | 4-氟異丁基芬太尼 | 4-Fluoroisobutyrfentanyl (4-FIBF, pFIBF) | N-(4-fluorophenyl)-N-(1-phenetylpiperidin-4-yl)isobutyramide |
| 127 | 四氫呋喃芬太尼 | Tetrahydrofuranylfentanyl (THF-F) | N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl] tetrahydrofuran-2-carboxamide |
| 128 | 對氟丁酰芬太尼 | Parafluorobutyrylfentanyl | N-(4-Fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide |
| 129 | 甲氧基乙酰芬太尼 | Methoxyacetylfentanyl | 2-Methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide |
| 130 | 環丙基芬太尼 | Cyclopropylfentanyl | N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide |
| 131 | 巴豆酰芬太尼 | Crotonylfentanyl | (E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide |
| 132 | 戊酰芬太尼 | Valerylfentanyl | N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide |
| 133 | 奧列巴文 | Oripavina | 3-O-demethylthebaine |
| 134 | 鄰氟芬太尼 | Orthofluorofentanyl | N-(2-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide |
| 135 | 異硝氮烯 | Isotonitazene | N,N-diethyl-2-[2-(4-isopropoxybenzyl)-5-nitro--1H-benzo[d]imidazol-1-yl]ethan-1-amine |
| 136 | 溴啡 | Brorphine | 11-[1-(4-bromophenyl)ethyl]-piperidin-4-yl1,3-dihydro-2H-benzimidazol-2-one |
| 137 | 甲硝苯 | Metonitazene | N,N-diethyl-2-[2-(4-methoxybenzyl)-5-nitro-1H--benzo[d]imidazol-1-yl]ethan-1-amine |
| 列於本附表之物質之具有特定化學名稱之異構物，然不包括明確不列入本附表之異構物。 | |||
| 列於本附表之物質之各形式之酯類及醚類，然不包括列於其他附表之酯類及醚類。 | |||
| 列於本附表之物質之鹽類，包括上述酯類、醚類及異構物之鹽類，只要屬該等鹽類之可能形式者。 | |||
| *右旋美沙芬(+)-3-甲氧基-N-甲基嗎啡喃及右旋芬(+)-3-羥基-N-甲基嗎啡喃均明確地不列入本表內。 | |||
表一 B
[編輯]| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 古柯葉- 可直接提取或透過化學方法獲得可卡因之Erythroxilon coca (Lamark)葉、Erythroxilon nova-granatense (Morris) Hieronymus及其變種之葉、Eritroxiláceas科之葉、該屬之其他品種之葉；古柯灌木葉，然不包括已完全提取出芽子鹼、可卡因及芽子鹼之任何其他衍生生物鹼之古柯灌木葉。 |
Coca, folha de- As folhas de Erythroxilon coca (Lamark), da Erythroxilon nova-granatense (Morris) Hieronymus e suas variedades, da família das eritroxiláceas e as suas folhas, de outras espécies deste género, das quais se possa extrair a cocaína directamente, ou obter-se por transformações químicas; as folhas do arbusto de coca, excepto aquelas de que se tenha extraído toda a ecgonina, a cocaína e quaisquer outros alcalóides derivados da ecgonina. |
|
| 2 | 可卡因 | Cocaína | methyl ester of benzoylecgonine |
| 3 | 可卡因-D-可卡因之右旋異構體 | Cocaína-D - isómero dextrógiro de cocaína. | |
| 4 | 芽子鹼- 及其酯類及可轉變為芽子鹼及可卡因之衍生物。 |
Ecgonina- e os seus ésteres e derivados que sejam convertíveis em ecgonina e cocaína. |
|
| 本附表所列複合物之所有可能存在之鹽類，均視為列入本附表內。 | |||
表一 C
[編輯]| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 大麻- Cannabis sativa L.植物之葉,或其開花或結果之頂部, 然並未從中提取出不論被冠以何種名稱之樹脂者。 |
Canabis-folhas e sumidades floridas ou frutificadas da planta Cannabis Sativa L. da qual não se tenha extraído a resina, qualquer que seja a denominação que se lhe dê. | |
| 2 | 大麻樹脂- 從大麻(cannabis) 植物取得的, 未經提煉或已提純之分離樹脂。 |
Canabis, resina de-resina separada, em bruto ou purificada, obtida a partir da planta Cannabis. | |
| 3 | 大麻油- 從大麻 (cannabis) 植物取得的, 未經提煉或已提純之分離油類。 |
Canabis, óleo de-óleo separado, em bruto ou purificado, obtido a partir da planta Cannabis. | |
| 本附表所列複合物之所有可能存在之鹽類，均視為列入本附表內。 | |||
表二 A
[編輯]| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 2,5-二甲氧基-4-溴苯己胺 | 2C-B | 4-bromo-2,5-dimethoxyphenethylamine |
| 2 | 丙硫苯乙胺 | 2C-T-7 | 4-propylthio-2,5-dimethoxyphenethylamine |
| 3 | 蟾酥鹼 | Bufotenina | 3-[2-(Dimethylamino)ethyl]-1H-indol-5-ol |
| 4 | 卡西酮 | Catinona | (–)-(S)-2-aminopropiophenone |
| 5 | 二乙基色胺 | DET | 3-[2-(diethylamino)ethyl]indole |
| 6 | 二甲氧基苯丙胺 | DMA | (±)-2,5-dimethoxy-α-methylphenethylamine |
| 7 | 二甲羥吡喃 | DMHP | 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol |
| 8 | 二甲基色胺 | DMT | 3-[2-(dimethylamino)ethyl]indole |
| 9 | 布苯丙胺 | DOB, Brolanfetamina | (±)-4-bromo-2,5-dimethoxy-α-methylphenethylamine |
| 10 | 二甲氧基乙基苯丙胺 | DOET | (±)-4-ethyl-2,5-dimethoxy-α-phenethylamine |
| 11 | 氨甲氧苯丙胺 | DOM, STP | 2,5-dimethoxy-α,4-dimethylphenethylamine |
| 12 | 二丙色胺 | DPT | N,N-dipropyltryptamine |
| 13 | 乙環利定 | Eticiclidina, PCE | N-ethyl-1-phenylcyclohexylamine |
| 14 | 乙基色胺 | Etriptamina | 3-(2-aminobutyl)indole |
| 15 | 苯環利定 | Fenciclidina, PCP | 1-(1-phenylcyclohexyl)piperidine |
| 16 | 麥角二乙胺，致幻劑，致幻劑-25 | Lisergida, LSD, LSD-25 | 9,10-didehydro-N,N-diethyl-6-methylergoline-8β-carboxamide |
| 17 | 2,5-二甲氧基苯丙胺 | MDA, Tenanfetamina | α-methyl-3,4-(methylenedioxy)phenethylamine |
| 18 | 二甲（甲烯二氧）苯乙胺 | MDMA | (±)-N,α-dimethyl-3,4-(methylenedioxy)phenethylamine |
| 19 | 甲羥芬胺 | MMDA | 5-methoxy-α-methyl-3,4-(methylenedioxy)phenethylamine |
| 20 | 三甲氧苯乙胺 | Mescalina | 3,4,5-trimethoxyphenethylamine |
| 21 | 4-甲基阿米雷司 | 4-metilaminorex | (±)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline |
| 22 | 甲基卡西酮 | Metilcatinona | 2-(methylamino)-1-phenylpropan-1-one |
| 23 | 4-甲硫苯丙胺 | 4-MTA | α-methyl-4-methylthiophenethylamine |
| 24 | 乙芬胺 | MDE, N-etil MDA | (±)-N-ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine |
| 25 | 羥芬胺 | N-hidroxi MDA | (±)-N-[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine |
| 26 | 六氫大麻酚 | Para-hexilo | 3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol |
| 27 | 副甲氧基苯丙胺 | PMA | p-methoxy-α-methylphenethylamine |
| 28 | 甲氧基甲基安非他明 | PMMA | Paramethoxymethylamphetamine(=N-methyl-1-(4-methoxyphenyl)-2-aminopropane) |
| 29 | 西洛西賓 | Psilocibina | 3-[2-(dimethylamino)ethyl]indol-4-yl dihydrogen phosphate |
| 30 | 裸頭草辛 | Psilocina, psilotsin | 3-[2-(dimethylamino)ethyl]indol-4-ol |
| 31 | 環丙胺吡咯烷 | Roliciclidina, PHP, PCPY | 1-(1-phenylcyclohexyl)pyrrolidine |
| 32 | 替諾環定 | Tenociclidina, TCP | 1-[1-(2-thienyl)cyclohexyl]piperidine |
| 33 | 三甲氧基苯丙胺 | TMA | (±)-3,4,5,-trimethoxy-α-methylphenethylamine |
| 34 | 卡西酮的衍生物*
- 任何在結構上可從2-氨基-1-苯基-1-丙酮通過以下方式衍生成之化合物： （1）在苯環上以不限數量之烷基、烷氧基、亞烷二氧基、鹵代烷基或鹵素取代，而不論生成物有否再在苯環上被一個或多個之單價取代基所取代； （2）在3位上以烷基取代； （3）在氮原子上以烷基、雙烷基取代，或把氮原子納入一個環狀結構。 - 任何在結構上可從2-氨基-1-丙酮之1位上以各種單環或稠環（不包括苯環或亞烷二氧苯環）衍生成之化合物，不論其有否再用以下方式作取代： （1）在苯環或稠環上以不限數量之烷基、烷氧基、鹵代烷基或鹵素取代，而不論生成物有否再在環上被一個或多個之單價取代基所取代； （2）在3位上以烷基取代； （3）在2-氨基之氮原子上以烷基或雙烷基取代，或把2-氨基之氮原子納入一個環狀結構。 |
Derivados da Catinona
- Qualquer composto derivado estruturalmente da 2-amino-1-phenyl-1-propanone por modificação de qualquer das seguintes formas: (1) por substituição de qualquer extensão no anel fenil pelos substituintes alcoíl, alcóxi, alquillenedioxi, haloalquil ou haleto, quer seja ou não ainda mais substituída no anel fenil por um ou mais substituintes univalentes; (2) por substituição na posição-3 com um substituinte alcoíl; (3) por substituição no átomo de azoto com os grupos alcoíl ou dialcoíl, ou por inclusão do átomo de azoto numa estrutura cíclica. - Qualquer composto derivado estruturalmente da 2-aminopropan-1-one por substituição na posição - 1 por qualquer sistema anelar monocíclico, ou policíclicos-fundidos (sem ser um sistema anelar fenil ou alquillenedioxifenil), se o composto é ou não: (1) por substituição de qualquer extensão no sistema anelar com substituintes alcoíl, alcóxi, haloalquil ou haleto, quer seja ou não ainda mais substituída no sistema anelar por um ou mais substituintes univalentes; (2) por substituição na posição – 3 por qualquer substituinte alcoíl; (3) por substituição do átomo 2-amino nitrogen pelos grupos alcoíl ou dialcoíl ou por inclusão do átomo 2-amino nitrogen numa estrutura cíclica. |
|
| 35 | 哌嗪的衍生物
- 1-苄基哌嗪。 - 任何在結構上可從1-苄基哌嗪或1-苯基哌嗪通過以下方式衍生成之化合物： （1）在哌嗪環的第2位氮原子上以烷基、苄基、鹵代烷基或苯基取代； （2）在芳香環上以不限數量之烷基、烷氧基、亞烷二氧基、鹵基或鹵代烷基取代。 |
Derivados da Piperazina
- 1-Benzilpiperazina. - Qualquer composto estruturalmente derivado da 1-benzilpiperazina ou 1- fenilpiperazina por modificação de qualquer das seguintes maneiras: (1) por substituição do segundo átomo de azoto no anel piperazina com os grupos alcoíl, benzil, haloalquíl ou fenil; (2) por substituição em qualquer extensão do anel aromático com os grupos alcoíl, alcóxi alquilenedioxi, haleto ou haloalquil. |
|
| 36 | 墨西哥鼠尾草 -Salvia Divinorum植物 |
Salvia Divinorum | |
| 37 | 丹酚A | Salvinorina-A | (2S, 4aR, 6aR, 7R, 9S, 10aS, 10bR)-9-(acetyloxy)-2-(3-furanyl) dodecahydro-6a, 10b-dimethyl-4, 10-dioxo-2H-naphtho [2,1-c] pyran-7-carboxylic acid methyl ester |
| 38 | N-（2-甲氧基苄基）-2-（2,5-二甲氧基-4-溴苯基）乙胺 | 25B-NBOMe | 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
| 39 | N-（2-甲氧基苄基）-2-（2,5-二甲氧基-4-氯苯基）乙胺 | 25C-NBOMe | 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
| 40 | N-（2-甲氧基苄基）-2-（2,5-二甲氧基-4-碘苯基）乙胺 | 25I-NBOMe | 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
| 41 | 副甲基甲米雷司 | 4,4』Dimethylaminorex(4,4』-DMAR) | para-methyl-4-methylaminorex |
| 42 | DOC | DOC | 4-chloro-2,5-dimethoxyamfetamine |
| 43 | 3-甲氧基苯環利定 | 3-Methoxyphencyclidine | 1-[1-(3-methoxyphenyl)cyclohexyl]piperidine |
| 44 | 二苯基乙基哌啶 | Diphenidine | 1-(1,2-diphenylethyl)piperidine |
| 本附表所列物質之可能存在之鹽類。 | |||
| 本附表所列物質之具有特定化學名稱之異構物，但明確不列入本附表之異構物除外。 | |||
| *卡西酮的衍生物中，安非他酮明確地不列入本表內。 | |||
表二 B
[編輯]| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 安不定 | Amineptina | 7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid |
| 2 | 苯丙胺 | Anfetamina | (±)-α-methylphenethylamine |
| 3 | 去甲麻黃鹼，(+)-降假麻黃鹼 | Catina, (+)-nor-pseudo efedrina | (+)-(S)-α-[(S)-1-aminoethyl]benzyl alcohol |
| 4 | 右旋苯丙胺 | Dexanfetamina | (+)-α-methylphenethylamine |
| 5 | 屈大麻酚∆ - 9- 四氫大麻酚及其立體化學變異體 | Dronabinol delta-9-tetrahidrocana binol e seus variantes estereoquímicos | (6aR,10aR)- 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
| 6 | 苯雙甲嗎啉 | Fendimetrazina | (+)-(2S,3S)-3,4-dimethyl-2-phenylmorpholine |
| 7 | 芬乃他林 | Fenetilina | 7-[2-[(α-methylphenethyl)amino]ethyl]theophylline |
| 8 | 苯甲嗎啉 | Fenmetrazina | 3-methyl-2-phenylmorpholine |
| 9 | 甲基苯乙基胺 | Fentermina | α,α-dimethylphenethylamine |
| 10 | 左旋苯丙胺 | Levanfetamina | (–)-(R)-α-methylphenethylamine |
| 11 | 左旋甲基苯丙胺 | Levometanfetamina | (–)-N,α-dimethylphenethylamine |
| 12 | 甲基苯丙胺 | Metanfetamina | (+)-(S)-N,α-dimethylphenethylamine |
| 13 | 外消旋甲基苯丙胺 | Metanfetamina, Racemato de | (±)-N,α-dimethylphenethylamine |
| 14 | 哌醋甲酯 | Metilfenidato | methyl α-phenyl-2-piperidine acetate |
| 15 | N,N-二甲基安非他命 | N,N-dimetanfetamina | N,N-dimethylamphetamine |
| 16 | 四氫大麻酚-右列異構體及其立體化學變異體。 | Tetraidrocanabinol-os isómeros e seus variantes estereoquímicos indicados na coluna seguinte. | 7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
(9R,10aR)-8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol (6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol (6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol 6a,7,8,9-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol (6aR,10aR)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
| 17 | 雙苯哌丙醇 | Zipeprol | α-(α-methoxybenzyl)-4-(β-methoxyphenethyl)-1-piperazineethanol |
| 18 | 合成大麻素
- 任何在結構上可從3-（1-萘甲酰基）吲哚或 1-H-吲哚-3基-1-萘甲酮通過在吲哚環之氮原子上以烷基、鏈烯基、環烷甲基、環烷乙基或2-（4-嗎啉基）乙基取代所生成之化合物，而不論生成物有否再在吲哚環或萘環以不限數量取代。 - 任何在結構上可從3-（1-萘甲酰基）吡咯通過在吡咯環之氮原子上以烷基、鏈烯基、環烷甲基、環烷乙基或2-（4-嗎啉基）乙基取代所生成之化合物，而不論生成物有否再在吡咯環或萘環以不限數量取代。 - 任何在結構上可從1-（1-萘甲基）茚通過在茚環之3-位上以烷基、鏈烯基、環烷甲基、環烷乙基或2-（4-嗎啉基）乙基取代所生成之化合物，而不論生成物有否再在茚環或萘環以不限數量取代。 - 任何在結構上可從3-苯乙酰基吲哚通過在吲哚環之氮原子上以烷基、鏈烯基、環烷甲基、環烷乙基或2-（4-嗎啉基）乙基取代所生成之化合物，而不論生成物有否再在吲哚環或苯環以不限數量取代。 - 任何在結構上可從2-（3-羥基環己基）酚通過在酚環之5-位上以烷基、鏈烯基、環烷甲基、環烷乙基或2-（4-嗎啉基）乙基取代所生成之化合物，而不論生成物有否再在己基環以不限數量取代。
|
Canabinoides Sintéticos
- Qualquer composto derivado estruturalmente do 3-(1-naphthoyl)indole ou 1Hindol-3-yl-(1-naphthyl)methanone por substituição no átomo de azoto do anel indol por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morfolinil)etil, quer seja ou não ainda mais substituído em qualquer extensão do anel indole quer seja ou não ainda mais substituído em qualquer extensão do anel naftaleno. - Qualquer composto derivado estruturalmente do 3-(1-naphthoyl)pyrrole por substituição no átomo de azoto do anel pirrol por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morpholinyl)ethyl, quer seja ou não ainda mais substituído em qualquer extensão do anel pirrol, quer seja ou não ainda mais substituído em qualquer extensão do anel naftaleno. - Qualquer composto derivado estruturalmente do 1-(1-naphthylmethyl)indene por substituição na posição - 3 do anel indeno por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morpholinyl)ethyl, quer seja ou não ainda mais substituído em qualquer extensão do anel pirrol, quer seja ou não ainda mais substituído em qualquer extensão do anel naphthyl. - Qualquer composto derivado estruturalmente do 3-phenylacetylindole por substituição no átomo de azoto do anel indole por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morpholinyl)ethyl, quer seja ou não ainda mais substituído em qualquer extensão do anel indole e quer seja ou não substituído em qualquer extensão do anel fenil. - Qualquer composto derivado estruturalmente do 2-(3-hydroxycyclohexyl)phenol por substituição na posição - 3 do anel fenól por alcoíl, alceno, cicloalcoílmetil, cicloalcoíletil ou 2-(4-morpholinyl)ethyl, quer seja ou não ainda mais substituído em qualquer extensão do anel ciclohexil. |
|
| 19 | 1-（1-萘甲酰基）-4-戊氧基萘 | CRA-13, CB-13 | Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone |
| 20 | [1-（5-氟戊基）-1H-吲哚-3-基]（萘-1-基）甲酮 | AM-2201 | [1-(5-Fluoropentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone |
| 21 | 哌乙酯 | Ethylphenidate | ethyl phenyl(piperidin-2-yl)acetate |
| 22 | 1-（2-噻吩基）-N-甲基-2-丙胺 | Methiopropamine(MPA) | N-methyl-1-(thiophen-2-yl)propan-2-amine |
| 23 | N-（1-甲氧基羰基-2,2-二甲基丙基）-1-（環己基甲基）吲哚-3-甲酰胺 | MDMB-CHMICA | methyl N[1-(cyclohexylmethyl)-1H-indol-3-yl] carbonyl3-methyl-L-valinate |
| 24 | N-（1-金剛烷基）-1-（5-氟戊基）吲唑-3-甲酰胺 | 5F-APINACA (5F-AKB-48) | N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide |
| 25 | [1-（5-氟戊基）-1H-吲哚-3-基]（2,2,3,3-四甲基環丙基）甲酮 | XLR-11 | [1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone |
| 26 | N-（1-氨甲酰基-2-甲基丙基）-1-（環己基甲基）-吲唑-3-甲酰胺 | AB-CHMINACA | N-[(2S)-1-amino-3-methyl-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide |
| 27 | 5F-ADB/ 5F-MDMB-PINACA | 5F-ADB/5F-MDMB-PINACA | methyl (2S)-2[1-(fluoropentyl)-1H-indazole-3-carbonyl]amino3,3-dimethylbutanoate |
| 28 | N-（1-氨甲酰基-2-甲基丙基）-1-戊基吲唑-3-甲酰胺 | AB-PINACA | N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide |
| 29 | 1-戊基-3-（2,2,3,3-四甲基環丙甲酰基）吲哚 | UR-144 | (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone |
| 30 | 1-（5-氟戊基）吲哚-3-甲酸-8-喹啉酯 | 5F-PB-22 | quinolin-8-yl 1- (5-fluoropentyl)-1H-indole-3-carboxylate |
| 31 | 4-氟苯丙胺 | 4-Fluoroamphetamine (4-FA) | 1-(4-fluorophenyl)propan-2-amine |
| 32 | ADB-FUBINACA | ADB-FUBINACA | N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide |
| 33 | FUB-AMB (MMB-FUBINACA, AMB-FUBINACA) | FUB-AMB (MMB-FUBINACA, AMB-FUBINACA) | Methyl(2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate |
| 34 | CUMYL-4CN-BINACA | CUMYL-4CN-BINACA | 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide |
| 35 | ADB-CHMINACA (MAB-CHMINACA) | ADB-CHMINACA (MAB-CHMINACA) | N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide |
| 36 | AB-FUBINACA | AB-FUBINACA | N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]indazole-3-carboxamide |
| 37 | 5F-AMB, 5F-AMB-PINACA | 5F-AMB, 5F-AMB-PINACA | methyl 2-({[1-(5-fluoropentyl)-1H-indazol-3yl]carbonyl}amino)-3-methylbutanoate |
| 38 | 5F-MDMB-PICA | 5F-MDMB-PICA | methyl(S)-2-[1-(5-fluoropentyl)-1H-indole-3-carboxamido]-3,3-dimethylbutanoate |
| 39 | 4F-MDMB-BINACA | 4F-MDMB-BINACA | methyl(S)-2-[1-(4-fluorobutyl)-1H-indazole-3-carboxamido]-3,3-dimethylbutanoate |
| 40 | C UMYL-PEGACLON | CUMYL-PEGACLON | 5-pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one |
| 41 | MDMB-4en-PINACA | MDMB-4en-PINACA | methyl 3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido]butanoate |
| 本附表所列物質之可能存在之衍生物及鹽類，以及由該等物質配有其他不論其作用如何之複合物調製而成之所有製劑。 | |||
表二 C
[編輯]| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 異戊巴比妥 | Amobarbital | 5-ethyl-5-isopentylbarbituric acid |
| 2 | 丁丙諾啡 | Buprenorfina | 2l-cyclopropyl-7-α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine |
| 3 | 布他比妥 | Butalbital | 5-allyl-5-isobutylbarbituric acid |
| 4 | 環巴比妥 | Ciclobarbital | 5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid |
| 5 | 伽馬-烴丁酸 | GHB | γ-hydroxybutyric acid |
| 6 | 格魯米特 | Glutetamida | 2-ethyl-2-phenylglutarimide |
| 7 | 氯胺酮 | Ketamina | (±)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone |
| 8 | 甲氯喹酮 | Mecloqualona | 3-(o-chlorophenyl)-2-methyl-4(3H)-quinazolinone |
| 9 | 甲喹酮 | Metaqualona | 2-methyl-3-o-tolyl-4(3H)-quinazolinone |
| 10 | 噴他佐辛 | Pentazocina | (2R*,6R*,11R*)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2- butenyl)-2,6-methano-3-benzazocin-8-ol |
| 11 | 戊巴比妥 | Pentobarbital | 5-ethyl-5-(1-methylbutyl)barbituric acid |
| 12 | 司可巴比妥 | Secobarbital | 5-allyl-5-(1-methylbutyl)barbituric acid |
| 13 | 2-（3-甲氧基苯基）-2-乙氨基環己酮 | Methoxetamine (MXE) | 2-(3-methoxyphenyl)-2-(ethylamino)-cyclohexanone |
| 14 | 氟胺酮 | 2-Fluorodeschloroketamine, 2-FDCK | 2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one |
| 本附表所列物質之可能存在之鹽類。 | |||
表三
[編輯]| 1 | 製劑：醋氫可待因；可待因；雙氫可待因；乙基嗎啡；嗎啉乙基嗎啡；6-煙鹼可待因；煙鹼酰二可待因；去甲可待因。以上製劑與其他一種或數種成分調配、每劑量單位藥物含量不超過100毫克且其濃度不超過整個製劑的2.5%。 |
| 2 | 丙吡胺製劑：每劑量單位含丙吡胺不超過100毫克並且與至少等量的甲基纖維素相調配。 |
| 3 | 右旋丙氧吩製劑：口服製劑，其每劑量單位含有不超過135毫克的右旋丙氧吩鹹或其濃度不超過整個製劑的2.5%，條件是這類製劑不含有根據1971年精神藥物公約加以管制的任何物品。 |
| 4 | 可卡因製劑：所含可卡因以可卡因鹹計算不超過0.1%；和阿片或嗎啡製劑：所含嗎啡以無水嗎啡鹹計算不超過0.2%，且因與一種或數種其他成分調配，致使其中的藥物不能以簡便方法回收或其分量構成對公眾健康的危害。 |
| 5 | 氰苯哌酸製劑：每劑量單位含有不超過0.5毫克的氰苯哌酸並含有至少相當於氰苯哌酸劑量5%的硫酸顛茄鹹。 |
| 6 | 地芬諾酯製劑：每劑量單位含有以鹹計算不超過2.5毫克的地芬諾酯並含有至少相當於地芬諾酯劑量1%的硫酸顛茄鹹。 |
| 7 | 複方阿片吐根散製劑：
10%阿片粉； 10%吐根散； 80%不含任何藥物的其他粉狀成分，細混合。 |
| 8 | 符合本表所列任一配方的製劑以及此項製劑與不含任何藥物的原料的混合物。 |
表四
[編輯]| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 二丙烯基巴比妥 | Alobarbital | 5,5-diallylbarbituric acid |
| 2 | 阿普唑侖 | Alprazolam | 8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine |
| 3 | 二乙胺苯丙酮 | Amfepramona, Dietilpropiona | 2-(diethylamino)propiophenone |
| 4 | 氨苯惡唑啉 | Aminorex | 2-amino-5-phenyl-2-oxazoline |
| 5 | 巴比妥 | Barbital | 5,5-diethylbarbituric acid |
| 6 | 苄甲苯異丙胺 | Benzefetamina | N-benzyl-N,α-dimethylphenethylamine |
| 7 | 溴西泮 | Bromazepam | 7-bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepine-2-one |
| 8 | 溴噻二氮䓬 | Brotizolam | 2-bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3- a][1,4]diazepine |
| 9 | 丁巴比妥 | Butobarbital | 5-butyl-5-ethylbarbituric acid |
| 10 | 卡馬西泮 | Camazepam | 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4- benzodiazepine-2-one dimethylcarbamate (ester) |
| 11 | 凱他唑侖 | Cetzolam | 11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-[1,3]oxazino[3,2-d][1,4]benzodiazepine-4,7(6H)-dione |
| 12 | 氯巴占 | Clobazam | 7-chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione |
| 13 | 氯硝西泮 | Clonazepam | 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepine-2-one |
| 14 | 氯氮䓬 | Clorazepato | 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3- carboxylic acid |
| 15 | 利眠寧 | Clordiazepóxido | 7-chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine-4-oxide |
| 16 | 氯噻西泮 | Clotiazepam | 5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-thieno[2,3-e]- 1,4-diazepine-2-one |
| 17 | 氯惡唑侖 | Cloxazolam | 10-chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydro-oxazolo-[3,2- d][1,4]benzodiazepine-6(5H)-one |
| 18 | 地洛西泮 | Delorazepam | 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one |
| 19 | 安定 | Diazepam | 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepine-2-one |
| 20 | 舒樂安定 | Estazolam | 8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine |
| 21 | 乙氯維諾 | Etclorvinol | 1-chloro-3-ethyl-1-penten-4-yn-3-ol |
| 22 | 乙非他明，N-乙基苯丙胺 | Etilanfetamina, N-etilanfetamina | N-ethylamphetamine-α-methylphenethylamine |
| 23 | 氯氟卓乙酯 | Etil-loflazepato | ethyl-7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4- benzodiazepine-3-carboxylate |
| 24 | 炔己蟻胺 | Etinamato | 1-ethynylcyclohexanol carbamate |
| 25 | 芬坎法明 | Fencanfamina | N-ethyl-3-phenyl-2-norbornanamine |
| 26 | 苯巴比妥 | Fenobarbital | 5-ethyl-5-phenylbarbituric acid |
| 27 | 芬普雷斯 | Fenproporex | (±)-3-[(α-methylphenylethyl)amino]propionitrile |
| 28 | 氟地西泮 | Fludiazepam | 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4- benzodiazepine-2-one |
| 29 | 氟硝西泮 | Flunitrazepam | 5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-7-2H-1,4-benzodiazepine-2-one |
| 30 | 氟安定 | Flurazepam | 7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro- 2H-1,4-benzodiazepine-2-one |
| 31 | 哈拉西泮 | Halazepam | 7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H-1,4- benzodiazepine-2-one |
| 32 | 鹵惡唑侖 | Haloxazolam | 10-bromo-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydroox azolo[3,2-d] [1,4]benzodiazepine-6(5H)-one |
| 33 | 勒非他明，二甲胺基二苯乙烷 | Lefetamina, SPA | (–)-N,N-dimethyl-1,2-diphenylethylamine |
| 34 | 氯普唑侖 | Loprazolam | 6-(o-chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepine-1-one |
| 35 | 芬拉西泮 | Lorazepam | 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4- benzodiazepine-2-one |
| 36 | 氯甲西泮 | Lormetazepam | 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4- benzodiazepine-2-one |
| 37 | 馬吲哚 | Mazindol | 5-(p-chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol |
| 38 | 美逹西泮 | Medazepam | 7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine |
| 39 | 美芬雷斯 | Mefenorex | N-(3-chloropropyl)-α-methylphenethylamine |
| 40 | 甲丙氨酯 | Meprobamato | 2-methyl-2-propyl-1,3-propanediol, dicarbamate |
| 41 | 雙苯斯酮胺 | Mesocarbe | 3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine |
| 42 | 甲基苯巴比妥 | Metilfenobarbital | 5-ethyl-1-methyl-5-phenylbarbituric acid |
| 43 | 甲乙哌啶酮 | Metiprilona | 3,3-diethyl-5-methyl-2,4-piperidine-dione |
| 44 | 咪逹唑侖 | Midazolam | 8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5- a][1,4]benzodiazepine |
| 45 | 硝甲西泮 | Nimetazepam | 1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepine-2-one |
| 46 | 硝西泮 | Nitrazepam | 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepine-2-one |
| 47 | 去甲西泮 | Nordazepam | 7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepine-2-one |
| 48 | 去甲羥安定 | Oxazepam | 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepine-2-one |
| 49 | 惡唑侖 | Oxazolam | 10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo[3,2- d][1,4]benzodiazepine-6(5H)-one |
| 50 | 匹嗎啉 | Pemolina | 2-amino-5-phenyl-2-oxazolin-4-one(=2-imino-5-phenyl-4-oxazolidinone) |
| 51 | 匹那西泮 | Pinazepam | 7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H-1,4-benzodiazepine- 2-one |
| 52 | 哌苯甲醇 | Pipradol | 1,1-diphenyl-1-(2-piperidyl)methanol |
| 53 | 焦二異丁基酮 | Pirovalerona | 4'-methyl-2-(1-pyrrolidinyl)valerophenone |
| 54 | 普拉西泮 | Prazepam | 7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-2H-1,4- benzodiazepine-2-one |
| 55 | 環乙丙甲胺 | Propil-hexedrina | 1-cyclohexyl-2-methylaminopropane |
| 56 | 仲丁比妥 | Secbutabarbital | 5-sec-butyl-5-ethylbarbituric acid |
| 57 | 替馬西泮 | Temazepam | 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4- benzodiazepine-2-one |
| 58 | 四氫西泮 | Tetrazepam | 7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1,4- benzodiazepine-2-one |
| 59 | 三唑侖 | Triazolam | 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4] benzodiazepine |
| 60 | 乙烯比妥 | Vinilbital | 5-(1-methylbutyl)-5-vinylbarbituric acid |
| 61 | 唑吡旦 | Zolpidem | N,N,6-trimethyl-2-p-tolylimidazo[1,2-a]pyridine-3-acetamide |
| 62 | 芬納西泮 | Phenazepam | 7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
| 63 | 氟阿普唑侖 | Flualprazolam | 8-chloro-6-(2-fluoro-phenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
| 64 | 依替唑侖 | Etizolam | 4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine |
| 65 | 氯氮唑侖 | Clonazolam | 6-(2-chlorophenyl)-1-methyl-8-nitro-4H- -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
| 66 | 二氯西泮 | Diclazepam | 7-chloro-5-(2-chlorophenyl)-1-methyl-1,3--dihydro-2H-benzo[e][1,4]diazepin-2-one |
| 67 | 氟溴唑侖 | Flubromazolam | 8-bromo-6-(2-fluorophenyl)-1-methyl-4H--benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
| 本附表所列物質之可能存在之鹽類。 | |||
表五
[編輯]| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 醋酸酐 | Anidrido acético | acetic oxide |
| 2 | N-乙酰鄰氨基苯酸 | Ácido N-acetilantranílico | 2-(acetylamino)-benzoic acid |
| 3 | 麻黃鹼 | Efedrina | [R-(R*,S*)]-[1-(methylamino)ethyl]-benzenemethanol |
| 4 | 麥角新鹼 | Ergometrina | [8ß(S)]- 9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide |
| 5 | 麥角胺 | Ergotamina | 12'-hydroxy-2'-methyl-5'α-(phenyl-methyl)-ergotaman-3',6',18'-trione |
| 6 | 異黃樟腦 | Isosafrole | 5-(1-propenyl)- 1,3-benzodioxole |
| 7 | 麥角酸 | Ácido lisérgico | (8ß)-9,10-didehydro-6-methylergoline-8-carboxylic acid |
| 8 | 3,4-亞甲基二氧苯基-2-丙酮 | 3,4-Metilenodioxif enil-2- propanona | 1-[3,4-(methylenedioxy)phenyl]- 2-propanone |
| 9 | 去甲麻黃鹼 | Norefedrina | (R*, S*)-α-(1-aminoethyl)benzenemethanol |
| 10 | 1-苯基-2-丙酮 | Fenilacetona /1-Fenil-2-propano na | 1-phenyl-2-propanone |
| 11 | 胡椒醛 | Piperonal | 1,3-benzodioxole-5-carboxaldehyde |
| 12 | 高錳酸鉀 | Permanganato de potássio | permanganic acid (HMnO4) potassium salt |
| 13 | 偽麻黃鹼 | Pseudoefedrina | [S-(R*,R*)].--[1-(methylamino)ethyl]-benzenemethanol |
| 14 | 黃樟腦 | Safrole | 5-(2-propenyl)-1,3-benzodioxole |
| 15 | 苯乙酸 | Ácido fenilacético | benzeneacetic acid |
| 16 | α-苯乙酰乙腈 | alfafenilacetoacetonitrilo | alpha-phenylacetoacetonitrile |
| 17 | 4-苯胺-N-苯乙基哌啶 | 4-Anilino-N-phenethylpiperidine (ANPP) | N-phenyl-1-(2-phenylethyl)piperidin-4-amine |
| 18 | N-苯乙基-4-哌啶酮 | N-Phenethyl-4-piperidone (NPP) | 1-(2-phenylethyl)piperidin-4-one |
| 19 | 3,4-亞甲基二氧苯基-2-丙酮甲基縮水甘油 | 3,4-MDP-2-P methyl glycidate | 2-oxiranecarboxylic acid, 3-(1,3-benzodioxol-5-yl)-2-methyl-, methyl ester |
| 20 | 3,4-亞甲基二氧苯基-2-丙酮甲基縮水甘油酸 | 3,4-MDP-2-P methyl glycidic acid | 2-oxiranecarboxylic acid, 3-(1,3-benzodioxol-5-yl)-2- methyl- |
| 21 | α-乙酰乙酰苯胺 | alpha-phenylacetoacetamide (APAA) | benzeneacetamide, α-acetyl- |
| 22 | α-苯乙酰乙酸甲酯（MAPA） | Methyl alpha-phenylacetoacetate (MAPA) | methyl 3-oxo-2-phenylbutanoate |
| 23 | 4-AP | 4-AP | 4-piperidinamine, N-phenyl- |
| 24 | 1-boc-4-A P | 1-boc-4-AP | 4-(phenylamino)-1-piperidinecarboxylic acid, 1,1-dimethylethyl ester |
| 25 | 去甲芬太尼 | Norfentanyl | propanamide, N-phenyl-N-4-piperidinyl- |
| 本附表所列物質之可能存在之鹽類。 | |||
| 本附表所列物質的具有特定化學名稱的異構物，但明確不列入本附表的異構物除外。 | |||
表六
[編輯]| 編號 | 中文名稱 | 葡文名稱 | 化學名稱∕結構 |
|---|---|---|---|
| 1 | 丙酮 | Acetona | 2-propanone |
| 2 | 鄰氨基苯甲酸 | Ácido antranílico | 2-aminobenzoic acid |
| 3 | 乙醚 | Éter etílico | 1,1』-oxybis[ethane] |
| 4 | 鹽酸 | Ácido clorídrico | hydrochloric acid |
| 5 | 甲基乙基酮/丁酮 | Metiletilcetona/Butanona | 2-butanone |
| 6 | 哌啶 | Piperidina | piperidine |
| 7 | 硫酸 | Ácido sulfúrico | sulfuric acid |
| 8 | 甲苯 | Tolueno | methyl-benzene |
| 本附表所列物質之可能存在之鹽類，但鹽酸鹽及硫酸鹽除外。 | |||
Public domainPublic domainfalsefalse